A Double Blind, Randomised, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Cannabis Based Medicine 1:1 THC:CBD Compared With Placebo for the Treatment of Spasticity in Patients With Multiple Sclerosis.
Phase of Trial: Phase III
Latest Information Update: 12 Sep 2014
At a glance
- Drugs Nabiximols (Primary) ; Cannabinoids
- Indications Multiple sclerosis; Muscle spasticity
- Focus Therapeutic Use
- Sponsors GW Pharmaceuticals
- 05 Nov 2010 New trial record.